Cargando…
Penetration through Outer Membrane and Efflux Potential in Pseudomonas aeruginosa of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
The treatment of infections by Gram-negative bacteria remains a difficult clinical challenge. In the light of the dearth of discovery of novel antibiotics, one strategy that is being explored is the use of adjuvants to enhance antibacterial activities of existing antibiotics. One such adjuvant is bu...
Autores principales: | Kim, Choon, Tomoshige, Shusuke, Lee, Mijoon, Zgurskaya, Helen I., Mobashery, Shahriar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952357/ https://www.ncbi.nlm.nih.gov/pubmed/36830269 http://dx.doi.org/10.3390/antibiotics12020358 |
Ejemplares similares
-
Total Syntheses of Bulgecins A, B, and C and Their
Bactericidal Potentiation of the β-Lactam Antibiotics
por: Tomoshige, Shusuke, et al.
Publicado: (2018) -
715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
por: Skalweit, Marion J, et al.
Publicado: (2019) -
Catalytic
Spectrum of the Penicillin-Binding Protein
4 of Pseudomonas aeruginosa, a Nexus for the Induction
of β-Lactam Antibiotic Resistance
por: Lee, Mijoon, et al.
Publicado: (2014) -
Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa
por: Gervasoni, Silvia, et al.
Publicado: (2022) -
Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
por: Skalweit, Marion J, et al.
Publicado: (2016)